salsolinol has been researched along with Adrenal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, M; Deng, Y; Duru, LN; Kaleem, U; Ma, H; Manzoor, R; Rasool, A | 1 |
| Dostert, P; Maruyama, W; Minami, M; Nagatsu, T; Naoi, M; Takahashi, A; Takahashi, T | 1 |
2 other study(ies) available for salsolinol and Adrenal Cancer
| Article | Year |
|---|---|
Synergistic Neuroprotective Effect of Endogenously-Produced Hydroxytyrosol and Synaptic Vesicle Proteins on Pheochromocytoma Cell Line Against Salsolinol.
Topics: Adrenal Gland Neoplasms; Animals; Catalase; Cytosol; Dopamine; Drug Synergism; Flavonoids; Glutathione Peroxidase; Hydrogen Peroxide; Isoquinolines; Malondialdehyde; Metabolome; Neuroprotective Agents; PC12 Cells; Phenylethyl Alcohol; Pheochromocytoma; Rats; Superoxide Dismutase; Synaptic Vesicles; Transcription, Genetic | 2020 |
Inhibition of tyrosine hydroxylase by R and S enantiomers of salsolinol, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline.
Topics: Adrenal Gland Neoplasms; Animals; Biopterins; Isoquinolines; Pheochromocytoma; Rats; Stereoisomerism; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 1992 |